Related Party Transactions
Year
-
Outcome of the 86th Annual General Meeting
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Newspaper Advertisement - Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Integrated Annual Report under Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Business Responsibility and Sustainability Report for the Financial Year 2024-25
-
Notice of the 86th Annual General Meeting (AGM) of the Company for FY 2024-25
-
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
-
Intimation to the holders of physical securities for furnishing of KYC details
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30- Newspaper Advertisement- Public Notice of 86th Annual General Meeting and Record Date
-
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Communication to Shareholders - Intimation on Tax Deduction on Dividend
-
Intimation of Schedule of Analysts/Institutional Investors Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of date of 86th Annual General Meeting and Record Date for payment of Dividend
-
Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter and financial year ended March 31, 2025
-
Intimation under Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 55 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter and financial year ended March 31, 2025
-
Newspaper Advertisement - Audited Consolidated and Standalone Financial Results for the quarter and financial year ended March 31, 2025
-
Outcome of the Board Meeting dated May 7, 2025: Approval of Audited Consolidated and Standalone Financial Results of the Company for the quarter and financial year ended
-
Outcome of the Board Meeting dated May 7, 2025: Recommendation of Dividend for Financial Year 2024-25
-
Re-appointment of Independent Director of the Company
-
Appointment of Secretarial Auditors of the Company
-
Press Release - Audited Consolidated and Standalone Financial Results of the Company for the quarter and financial year ended March 31, 2025
-
Analysts/ Investors presentation dated May 7, 2025 for the Audited Consolidated and Standalone financial results of the Company for the quarter and financial year ended March 31, 2025
-
Reminder letter to shareholders and advertisement for transfer of shares to Investor Education and Protection fund
-
Shareholding Pattern as on March 31, 2025
-
Intimation of the Board Meeting of the Company to be held on May 7, 2025
-
Intimation of Analysts/Investors Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation regarding Centralized Database for corporate bonds/ debentures
-
Intimation under Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of change in contact details of MUFG Intime India Private Limited, Registrar and Transfer Agent of the Company
-
Specifications related to ISINs for debt securities for the half-year ended March 31, 2025
-
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Integrated Filing (Governance) for the quarter ended March 31, 2025
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Transcript of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2024
-
Newspaper Advertisement - Unaudited Consolidated and Audited Standalone Financial Results for the third quarter and nine months ended December 31, 2024
-
Shareholding Pattern as on December 31, 2024
-
Outcome of the Board Meeting dated February 3, 2025- Approval of Unaudited Consolidated and Audited Standalone Financial Results of the Company for the third quarter and nine months ended December 31, 2024
-
Press Release- Unaudited Consolidated and Audited Standalone Financial Results of the Company for the third quarter and nine months ended December 31, 2024
-
Analysts/Investors presentation dated February 3, 2025 for Unaudited Consolidated and Audited Standalone Financial Results of the Company for the third quarter and nine months ended December 31, 2024
-
Integrated Filing (Financial) for the third quarter and nine months ended December 31, 2024
-
Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2024
-
Intimation of the Board Meeting of the Company to be held on February 3, 2025
-
Intimation of Analysts/Investors Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Schedule of Analysts/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation regarding change in name of Company’s Registrar and Transfer Agent (RTA)
-
Shareholding Pattern as on September 30, 2024
-
Shareholding pattern as on June 30, 2024
-
Integrated Filing (Governance) for the quarter ended December 31, 2024
-
Corporate Governance Report as on September 30, 2024
-
Corporate Governance Report as on June 30, 2024
-
Disclosure of Related Party Transactions for the half year ended March 31, 2025 pursuant to SEBI Regulations.
-
Disclosure of Related Party Transactions for the half year ended September 30, 2024 pursuant to SEBI Regulations
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
-
Intimation of Schedule of Analysts/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analysts/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulations 30 and 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
-
Intimation of Schedule of Analysts/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analysts/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Transcript of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2024
-
Newspaper Advertisement - Unaudited Consolidated and Audited Standalone Financial Results for the second quarter and half year ended September 30, 2024
-
Intimation of Re-scheduled Analyst/Institutional Investor Meeting under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Outcome of the Board Meeting dated October 17, 2024- Approval of Unaudited Consolidated and Audited Standalone Financial Results of the Company for the second quarter and half-year ended September 30, 2024
-
Press Release- Unaudited Consolidated and Audited Standalone Financial Results of the Company for the second quarter and half-year ended September 30, 2024
-
Analysts/Investors presentation dated October 17, 2024 for Unaudited Consolidated and Audited Standalone Financial Results of the Company for the second quarter and half-year ended September 30, 2024
-
Statement of utilisation of issue proceeds of NCDs
-
Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2024
-
Specifications related to ISINs for debt securities for the half year ended September 30, 2024
-
Intimation of the Board Meeting of the Company to be held on October 17, 2024
-
Intimation of Analysts/Investors Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 55 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analysts/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
-
Completion of tenure of an Independent Director
-
Intimation of under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Re-scheduled Analyst/Institutional Investor Meeting under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
-
Intimation under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
-
Outcome of the Meeting of the Internal Committee - Allotment of Non-Convertible Debentures (NCDs) on Private Placement basis
-
Transcript of Analysts/Investors Call pertaining to the Financial Results for the first quarter ended June 30, 2024
-
Outcome of the Meeting of Internal Committee – Issue of Non-Convertible Debentures aggregating to 1,700 crore rupees
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Newspaper Advertisement- Unaudited Consolidated and Audited Standalone Financial Results of the Company for the first quarter ended June 30, 2024
-
Outcome of the Board Meeting dated August 5, 2024- Approval of Unaudited Consolidated and Audited Standalone Financial Results of the Company for the first quarter ended on June 30, 2024
-
Press Release- Unaudited Consolidated and Audited Standalone Financial Results of the Company for the first quarter ended on June 30, 2024
-
Analysts/Investors presentation dated August 5, 2024 for Unaudited Consolidated and Audited Standalone Financial Results of the Company for the first quarter ended on June 30, 2024
-
Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2024
-
Stock Exchange Intimation of the Board Meeting of the Company to be held on August 5, 2024
-
Intimation of Analysts/Investors Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Outcome of the 85th Annual General Meeting
-
Intimation under Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Newspaper Advertisement - Disclosure under Regulations 30 and 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Notice of the 85th Annual General Meeting (‘AGM’) of the Company for FY 2023- 24
-
Integrated Annual Report under Regulation 34(1) of the SEBI (Listing Obligations and Disclosure) Regulations, 2015 (‘Listing Regulations’)
-
Business Responsibility and Sustainability Report for the Financial Year 2023-24
-
Intimation under Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30- Newspaper Advertisement- Public Notice of 85th Annual General Meeting and Record Date
-
Intimation of date of 85th Annual General Meeting and Record Date for payment of Dividend
-
Intimation to the holders of physical securities to furnish PAN, KYC details and Nomination as per SEBI Circular dated May 17, 2023
-
Reminder letter to shareholders and Advertisement for transfer of Shares to Investor Education and Protection Fund (IEPF)
-
Communication to Shareholders - Intimation on Tax Deduction on Dividend
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Change in the Senior Management Personnel of the Company
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Newspaper Advertisement - Audited Consolidated and Standalone Financial Results for the quarter and financial year ended March 31, 2024
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Re-appointment of Directors of the Company
-
Outcome of the Board Meeting dated April 29, 2024: Approval of Audited Consolidated and Standalone Financial Results of the Company for the fourth quarter and year ended March 31, 2024
-
Press Release - Audited Consolidated and Standalone Financial Results of the Company for the quarter and financial year ended March 31, 2024
-
Analysts/ Investors presentation dated April 29, 2024 for the Audited Consolidated and Standalone financial results of the Company for the quarter and financial year ended March 31, 2024
-
Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter and year ended March 31, 2024
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Stock Exchange Intimation for Update on the Board Meeting to be held on April 29, 2024
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
-
Stock Exchange Intimation of the Board Meeting of the Company to be held on April 29, 2024
-
Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter and financial year ended March 31, 2024
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
-
FITCH Ratings affirms Tata Chemicals Limited’s credit rating at BB+ & revises Outlook to Stable
-
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Transcript of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2023
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Newspaper Advertisement - Unaudited Consolidated and Audited Standalone Financial Results for the third quarter and nine months ended December 31, 2023
-
Outcome of the Board Meeting dated February 5, 2024: Approval of Unaudited Consolidated and Audited Standalone Financial Results of the Company for the third quarter and nine months ended December 31, 2023
-
Press Release on Unaudited Consolidated and Audited Standalone Financial Results for the third quarter and nine months ended December 31, 2023
-
Analyst/Investors Presentation dated February 5, 2024 for Unaudited Consolidated and Audited Standalone Financial Results for the third quarter and nine months ended December 31, 2023
-
Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2023
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation for the Board Meeting of the Company to be held on February 5, 2024
-
Intimation of Analyst’s Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on February 5, 2024
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Shareholding Pattern as on March 31, 2024
-
Shareholding Pattern as on December 31, 2023
-
Shareholding pattern as on September 30, 2023
-
Shareholding pattern as on June 30, 2023
-
Corporate Governance Report as on March 31, 2024
-
Corporate Governance Report as on December 31, 2023
-
Corporate Governance Report as on September 30, 2023
-
Corporate Governance Report as on June 30, 2023
-
Disclosure of Related Party Transactions for the half year ended March 31, 2024 pursuant to SEBI Regulations
-
Disclosure of Related Party Transactions for the half year ended September 30, 2023 pursuant to SEBI Regulations
-
Merger of Registrar & Transfer Agent i.e. TSR Consultants Private Limited with Link Intime India Private Limited
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Transcript of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2023
-
Newspaper Advertisement - Unaudited Consolidated and Standalone Financial Results for the second quarter and half yer ended September 30, 2023
-
Outcome of the Board Meeting dated November 10, 2023: Approval of Unaudited Consolidated and Audited Standalone Financial Results of the Company for the second quarter and half year ended September 30, 2023
-
Press Release on Unaudited Consolidated and Audited Standalone Financial Results for the second quarter and half year ended September 30, 2023
-
Analyst/Investors Presentation dated November 10, 2023 for Unaudited Consolidated and Audited Standalone Financial Results for the second quarter and half year ended September 30 2023
-
Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2023
-
Intimation under Regulation 30 of SEBI Listing Regulations – update on pending litigations
-
Intimation of Analyst’s Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on November 10, 2023
-
Intimation for the Board Meeting of the Company to be held on November 10, 2023
-
Reaffirmation of Credit Rating by CARE Ratings
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2023
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Newspaper Advertisement - Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2023
-
Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2023
-
Outcome of the Board Meeting dated August 7, 2023: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the quarter ended June 30, 2023
-
Press Release on Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2023
-
Analyst/Investors Presentation dated August 7, 2023 for Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2023
-
Intimation of Re-scheduled Analyst / Institutional Investor Meeting
-
Intimation for the Board Meeting of the Company to be held on August 7, 2023
-
Increase of shareholding in Rallis India Limited
-
Affirmation of Credit Rating by Moody’s
-
Outcome of the 84th Annual General Meeting
-
Newspaper Advertisement for Transfer of Shares to Investor Education and Protection Fund (IEPF)
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Newspaper Advertisement-Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Business Responsibility and Sustainability Report for the Financial Year 2022-23
-
Integrated Annual Report under Regulation 34(1) of the SEBI (Listing Obligations and Disclosure) Regulations, 2015
-
Notice of the 84th Annual General Meeting (‘AGM’) of the Company for FY 2022- 23
-
Re-affirmation of Credit Rating by CRISIL
-
Intimation regarding simplification of the holding structure of the US operations of Tata Chemicals Limited
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30 Newspaper Advertisement - 'Public Notice - 84th Annual General Meeting and Book Closure'
-
Submission of Annual Secretarial Compliance Report for the Financial Year 2022-23
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Communication to Shareholders - Intimation on Tax Deduction on Dividend
-
Intimation to the holders of physical securities to furnish PAN, shareholders KYC details and Nomination as per SEBI Circular dated March 16, 2023
-
Re-appointment of Director of the Company
-
Annual General Meeting of the Company and Intimation of Book Closure pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Newspaper Advertisement - Audited Standalone and Consolidated Financial Statements for the fourth quarter and year ended March 31, 2023
-
Audio Recording of the Analysts/Investors Call pertaining to the Financial Results for the fourth quarter and year ended March 31, 2023
-
Analyst/Investors Presentation dated May 3, 2023 for Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2023
-
Press Release on Financial Results for the fourth quarter and year ended March 31, 2023
-
Outcome of the Board Meeting dated May 3, 2023: Recommendation of Dividend for FY 2022-23
-
Outcome of the Board Meeting dated May 3, 2023: Approval of Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2023
-
Stock Exchange Intimation for the Board Meeting of the Company to be held on May 3, 2023
-
Voting Results of Postal Ballot through remote e-Voting
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Stock Exchange intimation - FITCH Ratings revises Tata Chemicals’ Outlook to Positive
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Newspaper Advertisement – Notice of Postal Ballot and E-Voting Information
-
Notice of Postal Ballot for re-appointment of Directors
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2022
-
Corrigendum to our letter dated February 1, 2023 intimating the re-appointment of Directors
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2022
-
Newspaper Advertisement - Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2022
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Outcome of the Board Meeting dated February 1, 2023: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2022
-
Press Release on Financial Results for the third quarter and nine months ended December 31, 2022
-
Analyst/Investors Presentation dated February 1, 2023 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2022
-
Re-appointment of Ms. Padmini Khare Kaicker as Independent Director and Mr. Zarir Langrana as Executive Director
-
Stock Exchange Intimation for the Board Meeting of the Company to be held on February 1, 2023
-
Shareholding Pattern as on March 31, 2023
-
Shareholding Pattern as on December 31, 2022
-
Shareholding pattern as on September 30, 2022
-
Shareholding pattern as on June 2022
-
Corporate Governance Report as on March, 2023
-
Corporate Governance Report as on December 31, 2022
-
Corporate Governance Report as on September 30, 2022
-
Corporate Governance Report as on June 30, 2022
-
Disclosure of Related Party Transactions for the half year ended March 31, 2023 pursuant to SEBI Regulations
-
Disclosure of Related Party Transactions for the half year ended September 30, 2022 pursuant to Regulation 23(9) of the SEBI Listing Regulations
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2022
-
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the Second Quarter and Half Year ended September 30, 2022
-
Stock Exchange Intimation for Audio Recording of Analyst/Investors Call pertaining to Financial Results for the second quarter and half year ended September 30, 2022
-
Outcome of the Board Meeting dated October 27, 2022: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half year ended September 30, 2022
-
Press Release on Financial Results for the second quarter and half year ended September 30, 2022
-
Analyst/Investors Presentation dated October 27, 2022 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half year ended September 30, 2022
-
Stock Exchange Intimation for the Board Meeting of the Company to be held on October 27, 2022
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Stock Exhange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the first quarter ended June 30, 2022
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the First Quarter ended June 30, 2022
-
Stock Exchange Intimation for Audio Recording of Analyst/Investors Call pertaining to Financial Results for the quarter ended June 30, 2022
-
Outcome of the Board Meeting dated August 9, 2022: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2022
-
Press Release on Financial Results for the first quarter ended June 30, 2022
-
Analyst/Investors Presentation dated August 9, 2022 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2022
-
Analyst/Investors Presentation dated August 9, 2022 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2022
-
Stock Exchange Intimation for the Board Meeting of the Company to be held on August 9, 2022
-
Reaffirmation of Credit Rating by CARE Ratings
-
Outcome of the 83rd Annual General Meeting
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation for Business Responsibility & Sustainability Report
-
Intimation for Notice and Explanatory Statement of the 83rd Annual General Meeting
-
Intimation for Integrated Annual Report for FY 2021-22
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Reaffirmation of Credit Rating by CRISIL Ratings
-
Intimation under Regulation 30 Newspaper Advertisement - 'Public Notice - 83rd Annual General Meeting'
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30 - Newspaper Advertisement for Transfer of Shares to Investor Education and Protection Fund (IEPF)
-
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2022
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Stock Exchange Intimation of Communication to Shareholders - Tax Deduction on Dividend
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Stock Exchange Intimation for Annual Disclosure for Fund raising by issuance of Debt Securities by Large Entities
-
Disclosure of Related Party Transactions for the half year ended March 31, 2022 pursuant to Regulation 23(9) of the SEBI Listing Regulations
-
Company's reply to the clarification sought by the exchange
-
Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter ended March 31, 2022
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Corrigendum to the Note 5 of the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2022
-
Stock Exchange Intimation for Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter ended March 31, 2022
-
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Consolidated Financial Results for the fourth quarter and year ended March 31, 2022
-
Press Release on Financial Results for the fourth quarter and year ended March 31, 2022
-
Outcome of the Board Meeting dated April 29, 2022: Recommendation of Dividend for FY 2021-22
-
Intimation of Book Closure pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Stock Exchange Intimation for Initial Disclosure for Fund raising by issuance of Debt Securities by Large Entities
-
Outcome of the Board Meeting dated April 29, 2022: Approval of Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2022
-
Re-appointment of Statutory Auditor of the Company
-
Analysts/Investors Presentation dated April 29, 2022 for Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2022
-
Change in name of Company’s Registrar and Transfer Agent (RTA)
-
Stock Exchange Intimation of the Board Meeting of the Company to be held on April 29, 2022
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Affirmation of Credit Rating by Fitch Ratings
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2021
-
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Stock Exchange Intimation for Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2021
-
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2021
-
Outcome of the Board Meeting dated February 10, 2022: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine-months ended December 31, 2021
-
Analysts/Investors Presentation dated February 10, 2022 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine-months ended December 31, 2021
-
Press Release on Financial Results for the third quarter and nine-months ended December 31, 2021
-
Stock Exchange Intimation of the Board Meeting of the Company to be held on February 10, 2022
-
Shareholding pattern as on March 2022
-
Shareholding pattern as on December 2021
-
Shareholding pattern as on September 2021
-
Shareholding pattern as on June 2021
-
Quarterly compliance report Q4 FY 22
-
Quarterly compliance report Q3 FY 22
-
Quarterly compliance report Q2 FY 22
-
Quarterly compliance report Q1 FY 22
-
Disclosure of Related Party Transactions for the half year ended March 31, 2022 pursuant to Regulation 23(9) of the SEBI Listing Regulations as per New Format
-
Disclosure of Related Party Transactions for the half year ended September 30, 2022 pursuant to SEBI Listing Regulations
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Disclosure of Related Party Transactions for the half year ended September 30, 2021 pursuant to Regulation 23(9) of the SEBI Listing Regulations
-
Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter ended September 30, 2021
-
Stock Exchange Intimation for Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2021
-
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the second quarter and half year ended September 30, 2021
-
Outcome of the Board Meeting dated October 27, 2021: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half-year ended September 30, 2021
-
Press Release on Financial Results for the second quarter and half-year ended September 30, 2021
-
Analysts/Investors Presentation dated October 27, 2021 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half-year ended September 30, 2021
-
Stock Exchange Intimation of the Board Meeting of the Company to be held on October 27, 2021
-
Reduction in rated amount and reaffirmation of credit rating by CARE Ratings
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2021
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Stock Exchange Intimation for Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2021
-
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2021
-
Outcome of the Board Meeting dated August 5, 2021: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2021
-
Press Release on Financial Results for the first quarter ended June 30, 2021
-
Analysts/Investors Presentation dated August 05, 2021 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2021
-
Stock Exchange intimation providing details of Analysts’ Call on the Audited Standalone and Unaudited Consolidated Financial Results for the first quarter ended June 30, 2021
-
Stock Exchange Intimation of the Board Meeting of the Company to be held on August 5, 2021
-
Outcome of the 82nd Annual General Meeting
-
Reaffirmation of Credit Rating by CARE Ratings
-
Stock Exchange Intimation for corrigendum to the Integrated Annual Report FY 2020-21
-
Intimation under Regulation 30 Newspaper Advertisement for Transfer of Shares to IEPF on June 12, 2021
-
Intimation under Regulation 30 - Newspaper Advertisement 'Notice of the 82nd Annual General Meeting, E-Voting and Book Closure'
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Notice and Explanatory Statement of the 82nd Annual General Meeting
-
Intimation under Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Integrated Annual Report for FY 2020-21
-
Reaffirmation of Credit Rating by CRISIL Ratings upon reduction in quantum of rated amount of Commercial Paper
-
Affirmation of Credit Rating by Moody’s Investors Service
-
Intimation under Regulation 30 Newspaper Advertisement - 'Public Notice - 82nd Annual General Meeting'
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Communication to Shareholders - Intimation on Tax Deduction on Dividend
-
Disclosure of Related Party Transactions for the half year ended March 31, 2021 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)
-
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2021
-
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2021
-
Outcome of the Board Meeting dated May 3, 2021: Approval of Audited Consolidated and Audited Standalone Financial Statements for the year ended March 31, 2021 and recommendation of Dividend
-
Outcome of Board Meeting dated May 3, 2021: Recommendation of Dividend for FY 2020-21
-
Intimation of Book Closure pursuant to Regulation 42 of SEBI Listing Regulations
-
Press Release dated May 3, 2021 for Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2021
-
Analysts/Investor Presentation dated May 3, 2021 for Audited Standalone and Consolidated Financial Results for FY 2020-21
-
Stock Exchange Intimation of the Board Meeting of the Company to be held on May 3, 2021
-
Newspaper publication of notice of the meeting of Board of Directors to be held on May 3, 2021 - English and Marathi
-
Intimation in terms of SEBI Circular No. SEBI/HO/MIRSD/DOS3/CIR/P/2018/139 dated November 6, 2018 pertaining to transfer of securities in physical mode
-
Disclosure under Regulation 30 (5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Newspaper Advertisement - Intimating change of the registered office of Registrar and Transfer Agent of the Company - TSR Darashaw Consultants Private Limited
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Change in Key Managerial Personnel (Chief Financial Officer) of the Company
-
Shifting of registered office of Registrar and Transfer Agent of the Company
-
Advertisement – Transfer of equity shares pursuant SEBI Circular dated November 6, 2018 - February 23, 2021
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Stock Exchange Intimation for Newspaper Publication of Financial Results for the third quarter and nine months ended December 31, 2020
-
Press Release on Financial Results for the third quarter and nine months ended December 31, 2020
-
Analysts/Investors Presentation dated January 28, 2021 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2020
-
Outcome of the Board Meeting dated January 28, 2021: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2020
-
Newspaper publication of notice of the meeting of Board of Directors to be held on January 28, 2021 - English and Marathi
-
Stock Exchange Intimation for the Board Meeting of the Company to be held on January 28, 2021
-
Clarification/confirmation on the news item appearing in Economic Times captioned ‘Tata Chemicals in advanced talks to buy debt-laden Archean unit’
-
Stock exchange intimation for withdrawal of Tata Chemicals (Soda Ash) Partners from the American Natural Soda Ash Corporation (ANSAC)
-
Shareholding pattern as on March 2021
-
Shareholding pattern as on December 2020
-
Shareholding pattern as on September 2020
-
Shareholding pattern as on June 2020
-
Quarterly compliance report Q4 FY 21
-
Quarterly compliance report Q3 FY 21
-
Quarterly compliance report Q2 FY 21
-
Quarterly compliance report Q1 FY 21
-
Disclosure of Related Party Transactions for the half year ended March 31, 2021 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)
-
Disclosure of Related Party Transactions for the half year ended September 30, 2020 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Disclosure dated December 7, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
-
Disclosures dated December 1 and December 3, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Stock exchange intimation for appointment of Mr. N. Chandrasekaran as an additional Director and Chairman of the Company
-
Stock exchange intimation for resignation of Mr. Bhaskar Bhat as a Director of the Company
-
Disclosure of Related Party Transactions for the half year ended September 30, 2020 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Stock Exchange Intimation for Newspaper Publication of Financial Results for the quarter and half year ended September 30, 2020
-
Outcome of the Board Meeting dated October 29, 2020: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2020
-
Press Release on Financial Results for the quarter and half year ended September 30, 2020
-
Analysts/Investors Presentation dated October 29, 2020 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2020
-
Newspaper publication of notice of the meeting of Board of Directors to be held on October 29, 2020 - English and Marathi
-
Stock Exchange Intimation for the Board Meeting of the Company to be held on October 29, 2020
-
Shifting of Investor Service Centers of Registrar and Transfer Agent of the Company
-
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2020
-
Disclosure dated September 25, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation for appointment of Mr. Rajiv Dube as an Independent Director
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Stock Exchange Intimation for Newspaper Publication of Financial Results for the quarter ended June 30, 2020
-
Outcome of the Board Meeting dated July 31, 2020: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2020.
-
Analysts/Investors Presentation dated July 31, 2020 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2020
-
Press Release on Financial Results for the first quarter ended June 30, 2020
-
Newspaper publication of notice of the meeting of Board of Directors to be held on July 31, 2020 - English and Marathi
-
Stock Exchange Intimation of the Board Meeting of the Company to be held on July 31, 2020
-
Outcome of the 81st Annual General Meeting
-
Disclosure regarding impact of Covid-19 pandemic on the Company’s operations - Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020
-
Confirmation by Tata Chemicals on non-applicability of SEBI Circular dated November 26, 2018 w.r.t. Large Corporates
-
Annual Disclosure by Tata Chemicals Limited being identified as a Large Corporate as on March 31, 2019
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Newspaper Advertisement for transfer of shares to IEPF Account
-
Newspaper Advertisement- Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
-
Submission of Annual Secretarial Compliance Report for the Financial Year 2019-20
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Notice and Explanatory Statement of the 81st Annual General Meeting
-
Intimation under Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Integrated Annual Report for FY 2019-20
-
Effective Date of Scheme of Merger by Absorption under Section 234 read with Section 230 to Section 232 of the Companies Act, 2013 of Bio Energy Venture – 1 (Mauritius) Pvt. Ltd (Transferor Company) by Tata Chemicals Limited (Transferee Company) and their respective shareholders
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Disclosure regarding impact of Covid-19 pandemic on the Company’s operations
-
Disclosure of Related Party Transactions for the half year ended March 31, 2020 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)
-
Corrigendum to the Audited Consolidated Financial Results for the year ended March 31, 2020
-
Effective Date of Scheme of Merger by Absorption under Section 234 read with Section 230 to Section 232 of the Companies Act, 2013 of Bio Energy Venture – 1 (Mauritius) Pvt. Ltd (Transferor Company) by Tata Chemicals Limited (Transferee Company) and their respective shareholders
-
Communication to Shareholders - Intimation on Tax Deduction on Dividend
-
Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Book Closure Date pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - 81st Annual General Meeting of the Company
-
Date of 81st Annual General Meeting of the Company
-
Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Cost of Acquisition of shares of Tata Chemicals Limited and Tata Consumer Products Limited (erstwhile Tata Global Beverage Limited) as per the provisions of Sections 49(2C) and 49(2D) of the Income Tax Act, 1961
-
Press Release dated May 15, 2020 for Audited Standalone and Audited Consolidated Financial Results for the year ended ended March 31, 2020
-
Outcome of the Board Meeting dated May 15, 2020: Approval of Audited Consolidated and Audited Standalone Financial Statements for the year ended March 31, 2020 and recommendation of Dividend
-
Rescheduling of Analysts' Call and Presentation to be made at the rescheduled call
-
Stock Exchange Intimation of the Board Meeting of the Company to be held on May 15, 2020
-
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) - Resuming of manufacturing operations at the Company’s plants
-
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) - Shutdown/ scale down of manufacturing operations at the Company’s plants due to outbreak of Coronavirus (COVID-19)
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Clarification on the disclosures submitted under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 on February 28, 2020 and March 5, 2020
-
Disclosure dated March 17, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
-
Purchase of shares by Mr. N. Chandrasekaran
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Disclosure dated March 3, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
-
Disclosure dated February 27, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
-
Disclosures dated February 18 and 19, 2020 received under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015: Inter-se transfers
-
Intimation of Newspaper advertisement for notice of Record Date
-
Intimation of the Record Date pursuant to Regulation 42 of SEBI LODR Regulations
-
Disclosure dated February 10, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation for Effective Date of the Scheme of Arrangement amongst Tata Chemicals Limited and Tata Global Beverages Limited
-
Stock exchange intimation of Newspaper Publication for Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2019
-
Outcome of the Board Meeting dated February 3, 2020: Approval of Unaudited Consolidated and Audited Standalone Financial Statements for the third quarter and nine months ended December 31, 2019
-
Press Release dated February 3, 2020 for Audited Standalone and Unaudited Consolidated Financial Results for third quarter and nine months ended December 31, 2019
-
Analysts/Investor Presentation dated February 3, 2020 for Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2019
-
Rescheduling of Analyst' call on the financial results for the third quarter and nine months ended December 31, 2019
-
Newspaper publication of notice of the meeting of Board of Directors to be held on February 3, 2020 - English and Marathi
-
Stock Exchange Intimation of the Board Meeting of the Company to be held on February 3, 2020
-
Intimation of sanction of Scheme of Arrangement by NCLT Mumbai and Kolkata Bench
-
Disclosure received under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Shareholding pattern as on March 2020
-
Shareholding pattern as on December 2019
-
Shareholding pattern as on September 2019
-
Shareholding pattern as on June 2019
-
Quarterly compliance report Q4 FY 20
-
Quarterly compliance report Q3 FY 20
-
Quarterly compliance report Q2 FY 20
-
Quarterly compliance report Q1 FY 20
-
Disclosure of Related Party Transactions for the half year ended March 31, 2020 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)
-
Disclosure of Related Party Transactions for the half year ended September 30, 2019 pursuant to Regulation-23-(9)-of-the-SEBI-(Listing-Obligations-and-Disclosure-Requirements)-Regulations-2015-('Listing-Regulations')
-
Intimation under Regulation 30 read with Schedule III of SEBI LODR - Acquisition of remaining 25% interest in Tata Chemicals (Soda Ash) Partners Holding
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Outcome of the National Company Law Tribunal Convened Meeting of Tata Chemicals Limited held on Wednesday, October 30, 2019
-
Newspaper Advertisement (Financial Results for the second quarter and half year ended September 30, 2019) - English
-
Newspaper Advertisement (Financial Results for the second quarter and half year ended September 30, 2019) - Marathi
-
Outcome of the Board Meeting dated October 30, 2019: Approval of Unaudited Consolidated and Audited Standalone Financial Statements for the second quarter and half year ended September 30, 2019
-
Newspaper publication of Notice of the Meeting of the Board of Directors to be held on October 30, 2019 - English
-
Newspaper publication of notice of the Meeting of the Board of Directors to be held on October 30, 2019 - Marathi
-
Stock Exchange Intimation of the Board Meeting of the Company to be held on October 30, 2019
-
Appointment of Mr. K.B.S. Anand as an Independent Director of the Company
-
Newspaper Advertisement of Notice of the Meeting of the Equity Shareholders of Tata Chemicals Limited to be convened pursuant to the directions of the Hon'ble National Company Law Tribunal, Mumbai Bench
-
Notice of the Meeting of Equity Shareholders of Tata Chemicals Limited convened pursuant to the directions of the Hon'ble National Company Law Tribunal, Mumbai Bench
-
Intimation of reappointment of Ms Vibha Paul Rishi as an Independent Director of the Company under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirement Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Cessation of Mr. Nasser Munjee and Dr. Y. S. P. Thorat as Independent Directors of the Company
-
Appointment of Dr. C V Natraj as an Independent Director of the Company
-
Newspaper Advertisement (Financial Results for the first quarter ended June 30, 2019) - Marathi
-
Newspaper Advertisement (Financial Results for the first quarter ended June 30, 2019) - English
-
Intimation of Appointment of Director under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015
-
Outcome of the Board Meeting dated August 8, 2019: Approval of Unaudited Consolidated and Audited Standalone Financial Statements for the quarter ended June 30, 2019
-
Press Release dated August 8, 2019 for Audited Standalone and Unaudited Consolidated Financial Results for first quarter ended June 30, 2019
-
Analysts/Investor Presentation dated August 8, 2019 for Audited Standalone and Unaudited Consolidated Financial Results for first quarter ended June 30, 2019
-
Newspaper publication of notice of the meeting of Board of Directors to be held on August 8, 2019 - Marathi
-
Newspaper publication of notice of the meeting of Board of Directors to be held on August 8, 2019 - English
-
Redemption of Non-Convertible Debentures (‘NCDs’) on due date and subsequent withdrawal of Credit Rating by CARE Ratings Limited
-
Intimation of the Board Meeting to be held on August 8, 2019
-
Redemption of Non-Convertible Debentures (‘NCDs’) on due date and subsequent withdrawal of Credit Rating by Brickwork Ratings India Private Limited
-
Outcome of the 80th Annual General Meeting
-
Intimation under Regulation 30 of the Listing Regulations for re-appointment of Ms. Vibha Paul Rishi as an Independent Director
-
Intimation under Regulation 57(1) of the Listing Regulations of payment of Principal along with Annual Interest to the Debentureholders of 2500 – 10% Rated Taxable Unsecured Redeemable Non-Convertible Debentures
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Newspaper publication of notice of the 80th Annual General Meeting of the Company
-
Annual Report for FY 2018-19 under Regulation 34(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Notice and Explanatory Statement of the 80th Annual General Meeting
-
Intimation under Regulation 50(1) and 60(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of Record Date and Payment of Principal, Interest and Redemption Date
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of Company’s Registrar and Share Transfer Agent update
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of Related Party Transactions for the half year ended March 31, 2019
-
Outcome of the Board Meeting held on May 15, 2019: Intimation of Scheme of Arrangement amongst Tata Chemicals Limited and Tata Global Beverages Limited and their respective shareholders and creditors
-
Intimation of Analyst / Investor Call held to discuss the Scheme of Arrangement amongst Tata Chemicals Limited and Tata Global Beverages Limited
-
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Newspaper Advertisement for Notice of transfer of shares to Investor Education and Protection Fund
-
Newspaper Advertisement (Financial Results for quarter and year ended March 31, 2019) - Marathi
-
Newspaper Advertisement (Financial Results for the quarter and year ended March 31, 2019) - English
-
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2019
-
Outcome of Board Meeting dated May 3, 2019: Approval of Standalone and Consolidated Financial Results for FY 2018-19
-
Outcome of Board Meeting dated May 3, 2019: Recommendation of Dividend for FY 2018 -19
-
Analysts/Investor Presentation dated May 3, 2019 for Standalone and Consolidated Financial Results for FY 2018-19
-
Press Release dated May 3, 2019 for Standalone and Consolidated Financial Results for FY 2018-19
-
Intimation of Book Closure pursuant to Regulation 42 of SEBI Listing Regulations
-
Newspaper publication of notice of the meeting of Board of Directors to be held on May 3, 2019 - English
-
Newspaper publication of notice of the meeting of Board of Directors to be held on May 3, 2019 - Marathi
-
Intimation of the Board Meeting to be held on May 3, 2019
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Newspaper Advertisement (Financial Results for quarter ended December 31, 2018) - English
-
Newspaper Advertisement (Financial Results for quarter ended December 31, 2018) - Marathi
-
Outcome of Board Meeting held on February 5, 2019 - Intimation under Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Presentation on the Analyst Call
-
Press Release on the Financial Results for the quarter ended December 31, 2018
-
Newspaper publication of notice of meeting of Board of Directors (05.02.2019) - English & Marathi
-
Intimation under Regulation 29 (1) (a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations)
-
Shareholding pattern as on March 2019
-
Shareholding pattern as on December 2018
-
Shareholding pattern as on September 2018
-
Shareholding pattern as on June 2018
-
Quarterly compliance report Q4 FY 19
-
Quarterly compliance report Q3 FY 19
-
Disclosure of Related Partv Transactions for the half year ended March 31. 2019 pursuant to Requlation 23(9) of the SEBI (Listino Obliqations and Disclosure Requirements) Requlations. 2015 ('Listinq Requlations')
-
Intimation of letter sent to shareholders holding shares in physical form for updating PAN and Bank details and converting their holdings into Demat
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Newspaper Advertisement (Financial Results for quarter and half year ended September 30, 2018) - Marathi
-
Newspaper Advertisement (Financial Results for quarter and half year ended September 30, 2018) - English
-
Non-convertible Debentures - Compliance of Regulations 52(4), 52(5) and 52(7) of SEBI Listing Regulations for the half year ended September 30, 2018
-
lntimation under Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Press Release on the Financial Results for the quarter ended September 30, 2018
-
MoU signed by the Company with CSIR – CECRI (Central Electrochemical Research Institute), Karaikudi
-
Newspaper publication of notice of meeting of Board of Directors (02.11.2018) - English & Marathi
-
Regulation 29 (1) (a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations)
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Newspaper Advertisement (Financial Results for first quarter ended June 30, 2018) - English
-
Presentation on the Analyst Call
-
lntimation under Regulations 30 and 33 of SEBI (Listinq Obligations and Disclosure Requirements) Regulations. 2015
-
Press Release on the Financial Results for the quarter ended June 30, 2018
-
Newspaper Advertisement (Financial Results for first quarter ended June 30, 2018) - Marathi
-
Notice of Board Meeting - August 13, 2018
-
Newspaper publication of notice of meeting of Board of Directors - Marathi
-
Newspaper publication of notice of meeting of Board of Directors - English
-
Intimation of change in Segment Reporting of Tata Chemicals Limited under Regulation 30 of the SEBI Listing Regulations
-
Outcome of the 79th Annual General Meeting
-
Webcast of 79th Annual General Meeting
-
Intimation under Reg. 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Newspaper Advertisement for notice of 79th AGM and Book Closure dates
-
Intimation under Reg. 57(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Payment of Annual Interest to Debentureholders
-
Notice of 79th Annual General Meeting
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Completion of acquisition of precipitated silica business of Allied Silica Limited
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation under Regulation 30 of SEBI Listing Regulations for sale and disposal of Phosphatic Fertilisers business and the Trading business to IRC Agrochemicals Private Limited effective June 1, 2018
-
Intimation under Regulation 30 of SEBI Listing Regulations for transfer of Ordinary Shares of the Company to Investor Education and Protection Fund
-
Intimation under Regulation 50(1) and 60(2) of SEBI Listing Regulations of Record Date and Payment of Interest Date
-
Outcome of Board Meeting dated May 18, 2018 approving the Standalone and Consolidated Financial Results for FY 2017-18 and declaration of Dividend.
-
Newspaper Advertisement (Financial Results for the Year Ended March 31, 2018) - Marathi
-
Newspaper Advertisement (Financial Results for the Year Ended March 31, 2018 - English
-
Press Release dated May 18, 2018 for Standalone and Consolidated Financial Results for FY 2017-18
-
Intimation under Regulation 30 of SEBI Listing Regulations regarding re-appointment of Mr. R. Mukundan as Managing Director and CEO.
-
Undertaking for the year ended March 31, 2018 pursuant to Regulation 57 of SEBI Listing Regulations
-
Details of Non-convertible Debentures for the year ended March 31, 2018 pursuant to Regulation 52(4) and 52(5) of SEBI Listing Regulations
-
Intimation of Book Closure pursuant to Regulation 42 of SEBI Listing Regulations (NSE)
-
Intimation of Book Closure pursuant to Regulation 42 of SEBI Listing Regulations (BSE)
-
Analysts/Investor Presentation dated May 18, 2018 for Standalone and Consolidated Financial Results for FY 2017-18
-
Analysts' Call on Audited Financial Results for the year ended 31st March 2018
-
Notice for potponement of Board Meeting- English
-
Notice for postponement of Board Meeting- Marathi
-
Postponement of Board Meeting to be held on May 7, 2018
-
Rescheduled Bord Meeting 6th May, 2018
-
Notice of Board Meeting - 7th May, 2018
-
Regulation 30 as 'BTA with ASL'
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation - Corrigendum to intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
lntimation under Reoulation 30 of the SEBI (Listinq Obliqations and Disclosure Requirements) Requlations. 2015
-
Stock Exchange Intimation under Regulation 30 - Appointment of Directors
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Analysts Presentation for Q3 Results dated 06.02.2018 of FY 2017-18
-
Press Release for Q3 Results dated 06.02.2018 of FY 2017-18
-
Outcome of Board Meeting dated 06.02.2018 for Q3 Results of FY 2017-18
-
Notice of Board Meeting - 6th February, 2018
-
Completion of Sale and Transfer of Urea and Customized Fertilisers Business to Yara Fertilisers India Private Limited (“Yara”)
-
Shareholding pattern as on March 2018
-
Shareholding pattern as on December 2017
-
Shareholding pattern as on September 2017
-
Shareholding pattern as on June 2017
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Compliance under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Postal Ballot 2017
-
Compliance under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Postal Ballot Notice
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Sanction of Scheme of Arrangement for the transfer of the business of Urea and customized fertilisers located at Babrala, Uttar Pradesh to Yara Fertilisers India Private Limited by NCLT, Mumbai Bench, Mumbai
-
Intimation of incorporation of new wholly owned subsidiary under Section 8 of the Companies Act, 2013
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Newspaper Advertisement (Quarter and Half Year Ended Results September 30, 2017) - English
-
Newspaper Advertisement (Quarter and Half Year Ended Results September 30, 2017) - Marathi
-
Press Release for Q2 Results dated 13.11.2017 of FY 2017-18
-
Analysts Presentation for Q2 Results dated 13.11.2017 of FY 2017-18
-
Outcome of Board Meeting dated 13.11.2017 for Q2 Results of FY 2017-18
-
Certificate under Regulation 52(4) & 52(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended September 30, 2017.
-
Intimation for Sale of Phosphatic Business
-
Press Release for Sale of Phosphatic Fertilisers Business
-
Newspaper publication of notice of meeting of board of directors - Navshakti
-
Newspaper publication of notice of meeting of board of directors - Business Standard
-
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Analysts call on 26th September, 2017
-
Sale of equity shares of Tata Global Beverages Limited
-
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Proposed Sale of equity shares of Tata Global Beverages Limited
-
Analysts call - 20th September, 2017
-
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015
-
Analysts call - 12th September, 2017
-
Annual Report 2016-17 under Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Outcome of Board Meeting for Q1 Results of FY 2017-18
-
Press Release for Q1 Results of FY 2017-18
-
Analysts Presentation for Q1 Results of FY 2017-18
-
Regulation 30 of the SEBI, LODR 2015 - Unnati Inorganics Private Limited - Cancellation of Transaction
-
Regulation 29 (1) (a) of the SEBI (Listing Obligations and disclosure requirements) regulations, 2015 - regulations of the Board Meeting - 08 August 2017
-
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Certilication under Regulation 57(l) of the SEBI (LODR) Regulations' 2015
-
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Outcome of board meeting in accordance with the SEBI (Listing obligations and disclosure requirements) regulations, 2015
-
Submission of presentation made to Analysts / Investors
-
Undertaking for the year ended 31st March, 2017 under Regulation 57 of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015
-
Details of Non-Convertible Debentures for the year ended March 31, 2017
-
Audited results for the Press Release for the year ended March 31, 2017
-
TCL NCLT Convened Meeting Proceedings and Voting Results 2017 BSE
-
Board Meeting
-
SE letter BTA Unnati Inorganics - Intimation under regulation 30 of the SEBI
-
Newspaper Advertisement of Equity Shareholders Meeting
-
Intimation under Regulation 30 of the SEBI (LODR) Regulations 2015
-
IEPF Advertisement - for Transfer of Shares to Investor Education and Protection Fund (IEPF) Account
-
Institutional Investor Meetings under the SEBI Requlations, 2015
-
Institutional Investor Meetinqs under the SEBI (LODR) Requlations, 2015
-
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015
-
Institutional Investor Meetings under the SEBI Requlations, 2015
-
lnstitutional lnvestor Meetings uncler the SEBI Requlations, 2015
-
SE Analyst Meet - Intimation of schedule of analyst
-
SE Letter Haldia - Intimation under regulation 30 of the SEBI
-
Regulation 30 (1) of the SEBI (Listing Obligations and disclosure requirements) regulations, 2015 - Outcome of the Board Meeting - 08 February 2017
-
Outcome of the Board Meeting - 08 February 2017
-
Presentation for Analysts' call - 08 February 2017
-
Press Release on Financial Results for the Q3 and nine months ended December 31, 2016
-
Memorandum of understanding (MOU) with Government of Andhra Pradesh
-
Board meeting notice for quarterly results - 08 February 2017
-
Credit Rating - Non-Convertible Debenture (NCD) of Rs. 250 crores
-
Shareholding pattern as on March 2017
-
Shareholding pattern as on December 2016
-
Shareholding pattern as on September 2016
-
Shareholding pattern as on June 2016
-
Credit ratings
-
Change in board of directors
-
Proceedings and voting results of the extra general meeting - 23 December 2016
-
Resignation of Mr Cyrus P Mistry as Director
-
Notice of motion number 3504
-
Representation of Mr Nusli N Wadia - Stock exchange letter
-
Notice of motion
-
Representation of Mr Cyrus P Mistry - Stock exchange letter
-
Analysts call announcement December 5, 2016
-
Notice of extraordinary general meeting - December 23, 2016
-
Analysts call announcement November 21-22, 2016
-
Outcome of the Board Meeting November 22, 2016
-
Analysts call announcement November 25, 2016
-
Analysts call announcement November 16, 2016
-
Resignation of Mr Bhaskar Bhat, non-executive, non independent director
-
Disclosure under Regulation 30 of the SEBl (Listing obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')
-
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
-
Resignation of Dr Nirmalya Kumar, non-executive director
-
NSE Email and Letter dated October 27, 2016 on News Clarification
-
Analysts call announcement November 11, 2016
-
Review of credit rating - NCD of Rs250 crore
-
Replacement of Mr Cyrus P Mistry as Chairman of Tata Sons Limited with Mr Ratan N. Tata as interim Chairman of Tata Sons Limited
-
MoU with Sanjana cryogenics - 12 September 2016
-
Eknath Kshirsagar retirement
-
Investor call intimation - 12 September 2016
-
Crisil rating
-
Investor meeting - 31 August 2016
-
Intimation of schedule of analyst/ institutional investor meetings - 23 August 2016
-
Board meeting notice for quarterly results 05 August 2016
-
Intimation under Regulation 30 of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015 (LODR) Regulations
-
Intimation of schedule of analyst/ institutional investor meetings
-
Intimation to the exchange pursuant to regulation 57(2) of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015
-
Details of nonconvertible debentures for the half vear ended March 31, 2016
-
Outcome of board meeting in accordance with the SEBI (Listing obliqations and disclosure requirements) regulations, 2015
-
Metahelix has entered into a joint venture with Mr Suresh Gobindram Vaswani
-
Appointment of Dr Nirmalya Kumar as an additional director
-
Details of non-convertible debentures for the half year ended March 31, 2016
-
Regulation 29 (1) of the SEBI (Listing Obligations and disclosure requirements) regulations, 2015 (LODR) regulations
-
lntimation of schedule of analyst / lnstitutional lnvestor meetinqs under the SEBI (Listino obliqations and disclosure requirements) requlations. 2015
-
Notice for board meeting - Q4 results
-
Babrala plant operations resumed
-
MoU with Sanjana Cryogenics Storage Ltd
-
Schedule of analyst / institutional investor meeting
-
Intimation under Regulation 30 of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015 (LODR) Regulations - 30 March 2016
-
Temporary shutdown of Babrala plant
-
Quarterly CG reports
-
Intimation under regulation 30 of the SEBI
-
Intimation under regulation 30 of the SEBI (Listing obligations and disclosure requirements) regulations, 2015
-
Regulation 30 (5) of the listing regulations
-
Shareholding pattern as on March 2016
-
Shareholding pattern as on December 2015
-
Shareholding pattern as on September 2015
-
Shareholding pattern as on June 2015
-
Quarterly compliance report Q2 FY 16
-
Quarterly compliance report Q1 FY 16
-
Retirement of Mr. R. Gopalakrishnan as non-executive director and vice chairman of the company
-
Resignation of Prasad R. Menon as non-executive, non-independent director
-
Appointment of Bhaskar Bhat as an additional director
-
Appointment of John Mulhall as the chief financial officer and key managerial personnel of the company
-
Retirement of PK Ghose, executive director and CFO
-
Resignation of Dr Vijay L Kelkar, non-executive independent director
-
Shareholding pattern as on March 2015
-
Shareholding pattern as on December 2014
-
Shareholding pattern as on September 2014
-
Shareholding pattern as on June 2014
-
Quarterly compliance report Q4 FY 15
-
Quarterly compliance report Q3 FY 15
-
Quarterly compliance report Q2 FY 15
-
Quarterly compliance report Q1 FY 15
-
Shareholding pattern as on March 2014
-
Shareholding pattern as on December 2013
-
Shareholding pattern as on September 2013
-
Shareholding pattern as on June 2013
-
Shareholding pattern as on March 2013
-
Shareholding pattern as on December 2012
-
Shareholding pattern as on September 2012
-
Shareholding pattern as on June 2012
-
Shareholding pattern as on March 2012
-
Shareholding pattern as on December 2011
-
Shareholding pattern as on September 2011
-
Shareholding pattern as on June 2011
-
Shareholding pattern as on March 2011
-
Shareholding pattern as on December 2010
-
Shareholding pattern as on September 2010
-
Shareholding pattern as on March 2010
-
Shareholding pattern as on December 2009
-
Shareholding pattern as on September 2009
-
Shareholding pattern as on June 2009
-
Shareholding pattern as on March 2009
-
Shareholding pattern as on December 2008
-
Shareholding pattern as on September 2008
-
Shareholding pattern as on June 2008
-
Analysts/Investor Presentation dated May 18, 2018 for Standalone and Consolidated Financial Results for FY 2017-18
No results found.
Clear all filters and try again.
Showing 1 of 100 results